GlassScriptPhysician profile
Mitesh S Amin
NPI 1801003157
$72,466.98
in general payments reported to CMS, 2019-2025
22 companies · $612 in 2025
The $612 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71K · 2020: $173 · 2021: $228 · 2022: $204 · 2023: $389 · 2024: $223 · 2025: $612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,224.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $41,448.87 | 2019 | |
| Janssen Pharmaceuticals, INC | $28,428.63 | 2019 | |
| Abbott Laboratories | $391.19 | 2019-2022 | |
| Boston Scientific Corporation | $369.00 | 2019-2025 | Watchman Flx, Patientcare Link |
| Medtronic Vascular, INC. | $368.87 | 2019-2020 | |
| Philips North America LLC | $263.46 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Medtronic, INC. | $195.82 | 2021-2024 | Venaseal, Symplicity G3, Hawkone |
| Biosense Webster, INC. | $180.03 | 2025 | Carto 3 |
| Impulse Dynamics (USA) INC. | $167.45 | 2023 | Optimizer |
| Kestra Medical Technology Services, INC. | $135.55 | 2023 | Assure Wcd |
| Pfizer INC. | $90.19 | 2019-2021 | |
| Amgen INC. | $71.48 | 2019-2025 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $67.10 | 2019-2023 | Lifevest |
| Scpharmaceuticals INC. | $61.11 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $59.90 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $50.00 | 2023-2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.02 | 2019-2020 | |
| Heartflow, INC. | $20.53 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $17.79 | 2019 | |
| Cordis US Corp. | $15.35 | 2022 | |
| Gilead Sciences, INC. | $15.07 | 2019 | |
| Itamar Medical INC | $10.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitesh Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.